Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial
Authors
Keywords
-
Journal
LEUKEMIA
Volume 30, Issue 2, Pages 261-267
Publisher
Springer Nature
Online
2015-08-18
DOI
10.1038/leu.2015.226
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correcting 2 more myths regarding transplants for AML in second remission
- (2014) R. P. Gale et al. BLOOD
- Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial
- (2014) J Schetelig et al. LEUKEMIA
- Relapsed acute myeloid leukemia: Why is there no standard of care?
- (2013) Farhad Ravandi BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival
- (2013) A. K. Burnett et al. BLOOD
- Early intervention with allogeneic hematopoietic cell transplantation during chemotherapy-induced aplasia in patients with high-risk acute myeloid leukemia
- (2013) F Stölzel et al. LEUKEMIA
- The myth of the second remission of acute leukemia in the adult
- (2012) S. J. Forman et al. BLOOD
- Treatment for relapsed acute myeloid leukemia
- (2012) Yishai Ofran et al. CURRENT OPINION IN HEMATOLOGY
- Clofarabine-containing conditioning regimen for allo-SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMT
- (2012) Patrice Chevallier et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Retrospective comparison of clofarabine versus fludarabine in combination with high-dose cytarabine with or without granulocyte colony-stimulating factor as salvage therapies for acute myeloid leukemia
- (2012) P. S. Becker et al. HAEMATOLOGICA
- Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial
- (2012) Stefan Faderl et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation
- (2011) Koen van Besien et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A Phase I Study in Adults of Clofarabine Combined with High-Dose Melphalan as Reduced-Intensity Conditioning for Allogeneic Transplantation
- (2011) Mark H. Kirschbaum et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies
- (2011) J. Magenau et al. BLOOD
- Early allo-SCT for AML with a complex aberrant karyotype—results from a prospective pilot study
- (2011) C Schmid et al. BONE MARROW TRANSPLANTATION
- Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia
- (2011) Pamela S. Becker et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome
- (2011) Stefanie Buchholz et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy
- (2010) F. Ravandi et al. BLOOD
- European Development of Clofarabine as Treatment for Older Patients With Acute Myeloid Leukemia Considered Unsuitable for Intensive Chemotherapy
- (2010) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Salvage chemotherapy regimens for acute myeloid leukemia: Is one better? Efficacy comparison between CLAG and MEC regimens
- (2010) Samantha L. Price et al. LEUKEMIA RESEARCH
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
- (2008) S. Faderl et al. BLOOD
- Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
- (2008) Richard F. Schlenk et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search